|
AstraZeneca
India launches new therapy for asthma
ASTRAZENECA Pharma India Ltd, the marketing company a leading pharmaceutical
company AstraZeneca, will participate in the global clinical trial
programme for asthma therapy and plans to conduct clinical trial
on Indian patients to get Indian data for single inhaler therapy
on asthma. The global trials are expected to begin in the first
quarter of 2004.
NPIL
to introduce three biotech drugs from new partnership
The countrys second largest pharma company in terms of market
share Nicholas Piramal India Ltd (NPIL) last week announced here
the introduction of two biotech drugs from its latest collaboration
with US based Biogen Idec Inc and Italian drug maker Chiesi Farmaceutici.
Novartis
anti-hypertensive Diovan has cardiac treatment potential: Study
SWISS pharma major Novartis blockbuster high blood pressure
drug Diovan (Valsartan), has the potential of a first-line therapy
for reducing cardiac events following a heart attack, according
to a study announced this year at the American Heart Association
Scientific Session and also published online in the New England
Journal of Medicine.
Dabur
Pharma eyes foray into cancer diagnostic services
THE Rs 183.8-crore Dabur Pharmaceuticals Ltd is exploring business
opportunities in the sophisticated diagnostic services and may set
up branded diagnostic centres in the country.
Reddy
moots research body to shape up state finances
RESERVE Bank Governor Dr Y V Reddy felt that there is a need for
a comprehensive methodology to go about on three key economic factors
- financial infrastructure, credit to agriculture and credit to
small-scale units - which will contribute aggressively to the growth
of states economy.
Surya
Pharma to raise Rs 13.50 crore through IPO in Dec
Chandigarh-based Surya Pharmaceutical Ltd is coming out with an
initial public offer (IPO) of 30 lakhs equity shares of Rs 10 each
for cash at a premium of Rs 35 each aggregating Rs 13.50 crores
in December.
Lincoln
Pharma launches Prolin - Natural
Lincoln Pharmaceuticals recently lunched its latest molecule, natural
micronised progesterone Prolin Natural.
At
a glance
|